Equities

Changmao Biochemical Engineering Co Ltd

Changmao Biochemical Engineering Co Ltd

Actions
  • Price (HKD)0.46
  • Today's Change0.00 / 0.00%
  • Shares traded152.00k
  • 1 Year change-16.36%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024 06:19 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments976459
Total Receivables, Net102118115
Total Inventory132161123
Prepaid expenses6.277.595.39
Other current assets, total1.611215
Total current assets338362317
Property, plant & equipment, net866773598
Goodwill, net------
Intangibles, net0.640.771.02
Long term investments3.774.13--
Note receivable - long term------
Other long term assets1511--
Total assets1,2421,207957
LIABILITIES
Accounts payable316796
Accrued expenses12227.79
Notes payable/short-term debt18810478
Current portion long-term debt/capital leases56349.08
Other current liabilities, total404866
Total current liabilities325274257
Total long term debt2511531.77
Total debt49529289
Deferred income tax0.600.530.45
Minority interest(0.1)0.360.43
Other liabilities, total140.040.06
Total liabilities591428259
SHAREHOLDERS EQUITY
Common stock535353
Additional paid-in capital103103103
Retained earnings (accumulated deficit)496623542
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.010.010.00
Total equity652779697
Total liabilities & shareholders' equity1,2421,207957
Total common shares outstanding530530530
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.